Drugmakers want more clarity from the Trump administration on the potential pharmaceutical tariffs, which some companies warn ...

Boston-based Verve is a rare example of a gene editing company targeting a disease that affects a large population, offering ...

Editas Medicine ( EDIT 12.04%) is a promising clinical-stage company that has captured Wall Street's attention at the ...

Texas hemp users stockpile products and consider moving out of state as ban looms, saying the medical marijuana program is an ...

Retail sales fell sharply in May as consumers pulled back after a sharp increase in spending in March to get ahead of ...

Capricor Therapeutics has received an orphan drug designation for its drug aimed at potentially treating Becker Muscular Dystrophy. The biotechnology company said Tuesday that the Food and Drug ...

The Trump family's latest venture, an "America first" mobile network and self-branded phone will "eventually" be built in the ...